Literature DB >> 21807077

No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.

Hikmet Akkız1, Süleyman Bayram, Aynur Bekar, Ersin Akgöllü, Oğuz Usküdar, Macit Sandıkçı.   

Abstract

AIM: MicroRNAs (miRNAs) are an abundant class of small non-protein coding RNAs with posttranscriptional regulatory functions as tumor suppressors and oncogenes. Aberrant expression and structural alteration of miRNAs are considered to participate in tumorigenesis and cancer development. It has been suggested that the presence of single nucleotide polymorphisms in precursor miRNAs (pre-miRNAs) can alter miRNA processing, expression, and/or binding to target mRNA and represent another type of genetic variability that can contribute to the susceptibility of human cancers. A G/C polymorphism (rs2910164), which is located in the sequence of miR-146a precursor, results in a change from G:U to C:U in its stem region.
METHODS: To determine the association of the miR-146a rs2910164 polymorphism on the risk of hepatocellular carcinoma (HCC) development in Turkish population, a hospital-based case-control study was designed consisting of 222 subjects with HCC and 222 cancer-free control subjects matched on age, gender, smoking and alcohol status. The genotype frequency of miR-146a rs2910164 polymorphism was determined by using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay.
RESULTS: No statistically significant differences were found in the allele or genotype distributions of the miR-146a rs2910164 polymorphism among HCC and cancer-free control subjects (p>0.05).
CONCLUSION: Our results demonstrate that the miR-146a rs2910164 polymorphism has no major role in genetic susceptibility to hepatocellular carcinogenesis, at least in the population studied here. Independent studies are needed to validate our findings in a larger series, as well as in patients of different ethnic origins.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807077     DOI: 10.1016/j.gene.2011.07.006

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  36 in total

1.  MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population.

Authors:  Youchao Jia; Aimin Zang; Yanhong Shang; Hua Yang; Zizheng Song; Zhiyu Wang; Lili Ren; Yaning Wei; Ling Hu; Hongyun Shi; Hefei Li
Journal:  Med Oncol       Date:  2014-08-26       Impact factor: 3.064

Review 2.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 3.  Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

Authors:  Xia Hao; Lingzi Xia; Ruoyi Qu; Xianglin Yang; Min Jiang; Baosen Zhou
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

4.  Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis.

Authors:  Zhihua Yin; Lei Yan; Zhigang Cui; Xuelian Li; Yangwu Ren; Baosen Zhou
Journal:  Mol Biol Rep       Date:  2013-01-06       Impact factor: 2.316

5.  MiR-146a rs2910164 polymorphism is associated with hepatocellular carcinoma: a meta-analysis.

Authors:  Jiajun Chen; Xuedong Cao; Haiyang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  MicroRNA-146a rs2910164 polymorphism and the risk of diffuse large B cell lymphoma in the Chinese Han population.

Authors:  Haifeng Zhuang; Jianping Shen; Zhiyin Zheng; Xiusu Luo; Ruilan Gao; Xiaofen Zhuang
Journal:  Med Oncol       Date:  2014-11-05       Impact factor: 3.064

7.  Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer.

Authors:  Hanan S Elsarraj; Shane R Stecklein; Kelli Valdez; Fariba Behbod
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-19       Impact factor: 2.673

8.  Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.

Authors:  Shuzhe Yao; Jianping Zhang; Haiyan Chen; Yan Sheng; Xiaoying Zhang; Zhiyan Liu; Cuijuan Zhang
Journal:  J Histochem Cytochem       Date:  2013-05-16       Impact factor: 2.479

9.  Association of NFKB1A and microRNAs variations and the susceptibility to atherosclerosis.

Authors:  Tuba Oner; Caner Arslan; Guven Yenmis; Berk Arapi; Cigdem Tel; Birsen Aydemir; Gonul Kanigur Sultuybek
Journal:  J Genet       Date:  2017-06       Impact factor: 1.166

Review 10.  Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk.

Authors:  Kshitij Srivastava; Anvesha Srivastava
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.